Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine. We develop science-led, accessible treatment approaches designed to open new routes for brain health and help people reclaim more vibrant lives. From day one, we have been powered by a radical idea: treatments for anxiety and depression should bring real relief. ​
​
Together we’re moving psychiatry forward— beyond better, into a boundless future.​
​
Definium Therapeutics trades on the NASDAQ under the symbol DFTX.

Biotechnology

Definium Therapeutics

MindMed's headquarters in New York, NY, United States

The Toronto office likely supports executive leadership and administrative functions for strategic operations.

Toronto

The Advisory and Strategy Team at MindMed provides expert guidance on strategic initiatives, assists in shaping the company’s long-term vision, and supports the development and deployment of psychedelic-inspired therapies. They leverage their collective experience to influence key decisions, ensuring alignment with MindMed’s mission to address addiction and mental illness.

Advisory and Strategy Team

This department oversees the development and oversight of clinical and regulatory strategies to ensure compliance and effectiveness in medical product development.

Clinical and Regulatory Affairs

The Clinical Operations and Development team at MindMed is responsible for planning, coordinating, and overseeing clinical trials and development programs for psychedelic-inspired medicines aimed at treating addiction and mental illness. This team ensures that clinical trials are conducted efficiently, compliantly, and effectively to bring new therapies from concept through to market approval.

Clinical Operations and Development

The Leadership Team at MindMed plays a pivotal role in shaping the company's strategic direction and overseeing its operations in the psychedelic medicine space. Comprising executives from various functions, such as medical, commercial, and financial disciplines, the team collaborates to drive the development and deployment of innovative therapies for addiction and mental illness, ensuring alignment with regulatory requirements and market needs while fostering a culture of scientific excellence and ethical responsibility.

Leadership Team

The Product Development & Management team at MindMed oversees the entire lifecycle of psychedelic-inspired medicines, from initial discovery through to clinical deployment. This team collaborates to ensure effective pharmaceutical development, rigorous clinical testing, and strategic portfolio management to bring innovative treatments for addiction and mental illness to market.

Product Development & Management

This department oversees high-level management and strategic direction across various corporate functions.

��

People (15)

Jobs (0)

Other teams

Clinical and Regulatory Affairs

Clinical Operations and Development

Leadership Team

Product Development & Management

Corporate Leadership

��������

People (15)

Jobs (0)

Other teams

Clinical and Regulatory Affairs

Clinical Operations and Development

Leadership Team

Product Development & Management

Corporate Leadership

��